University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Levetiracetam tablets
Status: Amber Levofloxacin

Eye drops - high relative cost - second line. Use SDU if using one or two hourly, or if significant OSD/toxicity.

Status: Amber Levofloxacin (SDU)
Status: Amber Levomepromazine injection

Consultant initiation only

Status: Amber Levomepromazine tablets (Nozinan®)

Consultant initiation only, ESCA

Status: Amber Lidocaine 5% patch

For patients who have been treated in line with NICE CG173 Neuropathic pain in adults: pharmacological management in non-specialist settings but are still experiencing neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia)

Status: Amber Lignocaine 5% medicated plasters (30 plasters)

RICaD

Status: Amber Linaclotide

For moderate to severe IBS-Constipation. For patients who have not responded adequately to or cannot tolerate all other suitable treatment options BUT BEFORE other agents with higher costs.

Status: Amber Liothyronine tablets

ESCA in development

Status: Amber Lisdexamfetamine

ESCAs and additional advice in relation to age of patient and CCG

Building healthier lives
Back to top